eMalick Njie is the CEO and Founder of Ecotone AI, a biotech company focused on designing AI-driven medicines to cure rare inherited diseases. He is also the Co-Founder of Genetic Leap, which applies AI and RNA-based approaches to accelerate drug development and address urgent health needs.
Before entering industry, eMalick was a Senior Scientist at Columbia University in the lab of Nobel laureate Martin Chalfie, where he discovered key genes involved in neural ensheathment and touch sensation in C. elegans. He brings deep scientific insight and a bold vision for the future of genetic medicine.
